A 28-year-old woman was admitted to the hospital because of severe hypoxemia and right heart failure that had been caused by ...

“Corporatization” of health care, a process predicted decades ago, now refers to the general trend throughout the industry toward higher levels of integrated control by consolidated profit-seeking ...

Though infant mortality has continuously been targeted by health policy agendas, policies tend to place it in an individualistic and narrow frame, failing to consider and address its structural ...

The rising tide of chronic kidney disease among patients with type 2 diabetes continues to challenge clinicians and health systems worldwide.1 Advances have been made in the management of chronic k ...

To the Editor: In the 2IQP trial, Kudva and colleagues (May 8 issue) 1 found that in adults with insulin-treated type 2 diabetes, automated insulin delivery (AID) led to a greater reduction in ...

The need to suppress a patient’s immune system after the transplantation of allogeneic cells is associated with wide-ranging side effects. We report the outcomes of transplantation of ...

Understanding today’s corporatization of U.S. health care requires seeing it from a historical perspective, as a process that began with a change in the business model of care delivery in the 1920s.

To prevent the spread of inaccurate information, academic and health care institutions will need to equip scientists and clinicians to engage effectively on nontraditional media platforms.

This Double Take video explores the link between certain strains of human papillomavirus and cancer and reviews the evidence ...

The extreme reductions that the Trump administration is making at the vital, mission-driven Centers for Disease Control and Prevention amount to unilateral disarmament against health hazards.

In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone ...

AI mammography aids are being sold as additions to mammography screening, with direct-to-consumer marketing touting improved cancer-detection rates, despite a lack of evidence of clinical effective ...